OKYO Pharma Limited (OKYO) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

OKYO Pharma Limited (OKYO) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $64.8M, listed on NASDAQ, employing roughly 3 people, carrying a beta of -0.05 to the broader market. OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Led by Robert J. Dempsey, public since 2022-05-17.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for OKYO as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →